toll free call 877-225-8384Mon - Fri 7am - 7pm Sat 8am - 4pm (CST) Sun: Closed

The world's most powerfully practical™
Psychopharmacology Course

Great news - the entire Master Psychopharmacology Course is now available as a completely pharma-free Online Course. Now you can share in all the lectures and information from the course at your own pace, in your own home.

Online Course Materials

With the Master Psychopharmacology Course, you receive access to all of the course lectures as streaming video on the web that you can review whenever you want, as often as you want. You’ll also have access to each presentation on your mobile device – review anytime, anywhere!

So, let me share with you the reasons to order the Master Psychopharmacology Course today.

Powerfully Practical Psychopharmacology Course

We have bent over backwards to ensure that the Master Psychopharmacology Course provides you with the most powerfully practical, down-in-the trenches, practice-relevant, immediately usable prescribing guidance you have ever received from any psychiatric course or conference that you have attended.

Unlike other courses, the single-minded goal of The Master Psychopharmacology Course is to ensure your ability to implement what you learn. After all, it doesn’t matter what great things you hear and see if you don’t make use of them once you’re back in the office, sitting across your desk from a complex, treatment-resistant patient.

Earn Up to 8 Self-Assessment Credits

To meet the ABPN's new requirements to sit for the MOC exam, we are providing up to 8 Self-Assessment Credits for participating. Regardless of whether you have an MOC exam coming up in 1 year or in 9 years, you need to start earning Self-Assessment credits now! We're including 8 Self-Assessment credits with this course to make it easy for you to keep up (or catch up!) with these new requirements.

Earn Up to 25 Category 1 CME Credits

These CME hours are included in your course tuition. You earn 17 CME credits for the Master Psychopharmacology Course, and 8 CME Credits for participating in the 1-Day Medical Intensive. Note that many employers, group practices and training programs will reimburse you for the costs of this Category 1 CME activity. So be sure to ask!

Get Online Access

You receive flexible online access to the content. Every lecture is accessible as both streaming webinars on your computer and as mobile video on your mobile device. Participants appreciate the chance to review the lectures to their heart’s content! We also ship you the detailed course syllabus to aid your study and help you take notes.

So, to start accessing the proven, practical, and up-to-date guidance in the Master Psychopharmacology Online Course, register online or call us today. Hundreds of your colleagues already have - and we have the testimonials to prove it!

Sincerely,

Jack Krasuski MD

Jack Krasuski MD
Executive Director

CME and SA credits for this product are good through 8/15/2015

Top

Course Agenda


MEDICAL UPDATE FOR THE PSYCHIATRIST – 8 CME CREDITS

1 Hour
Psychiatric Manifestations of Neurologic Disease
  • The High-Yield 5-Minute Neuro Exam
  • When To Order Neuroimaging Studies
  • Neurological Side-Effects Of Psychotropics
  • Updates on Dementia, Parkinson's, MS, Stroke, and TBI
  • Safe Psychotropic Prescribing in Patients with Seizure Disorders
Jeff Bronstein, MD
1 Hour
Renal Disease in Psychiatric Practice
  • Role Of Lithium In The Production Of Acute Renal Failure
  • Depression, Anxiety, Suicide And Delirium In Patients on Dialysis
  • Safe Psychotropic Prescribing In Patients With Renal Disease
Vito Campese, MD
1 Hour
Cardiovascular Conditions in Psychiatric Practice
  • Chest Pain – When To Assess It Further?
  • Understanding Dysrhythmias
  • Safe Psychotropic Prescribing In Patients With Cardiovascular Disease
Michael Cao, MD
1 Hour
Hepatic Disease in Psychiatric Practice
  • Abnormal LFT’s – What Do They Mean?
  • Hepatitis C Treatment And Impact Of Psychiatric Conditions
  • Managing Patients With Alcoholic Hepatitis And Cirrhosis
  • Safe Psychotropic Prescribing In Patients With Hepatic Disease
Michelle Pietzak, MD
1 Hour
Metabolic Conditions in Psychiatric Practice
  • Metabolic Conditions Defined
  • Relationship Between Obesity And Metabolic Conditions
  • Obesity: Causes And Consequences
  • Link Between Metabolic Conditions And Schizophrenia, Including The Role Of Antipsychotic Medications
  • Standard Of Care For Assessing Metabolic Conditions In A General Psychiatry Practice
  • First Line Management Of Obesity And Metabolic Conditions In Patients With Severe Mental Illness
Wei-An Lee, DO
1 Hour
Thyroid Disorders in Psychiatric Practice
  • Comorbid Thyroid and Psychiatric Disorders
  • Thyroid Tests For Patients with a Psychiatric Diagnosis
  • Managing Hypothyroidism
  • Use of Thyroid Hormones and Treatment
Wei-An Lee, DO
1 Hour
Pain Management for the General Psychiatrist
  • Psychiatrist Role in Assessment and Management of Pain Conditions
  • Dual-Use Psychiatric/Pain Medication
  • Prescription Medication Abuse in the Pain Patient
Steven Richeimer, MD

2012 MASTER PSYCHOPHARMACOLOGY COURSE - 17 CME/8 SA CREDITS


2 Hours
Course And Treatment Of Mood Disorders During Pregnancy
  • Review The Course Of Psychiatric Illness During Pregnancy
  • Available Pharmacologic Treatment Options For Treating The Spectrum Of Psychiatric Disorders Seen In Reproductive Age Women
  • Treatment Algorithms For Use Of The Range Of Psychotropics During Pregnancy
    • Antidepressants
    • Mood Stabilizers
    • Antipsychotics
    • Benzodiazepines
Lee Cohen, MD
2 Hours
Screening And Treatment Of Postpartum Psychiatric Disorders : An Update
  • Review The Various Screening Tools Which Are Available To Identify PPD
  • Data From The Array Of Pharmacologic And Non-Pharmacologic Treatment Studies Of PPD Will Be Critically Reviewed So That Clinicians Can Choose The Ideal Treatment To Match The Variety Of Postpartum Presentations Seen In Clinical Practice
Lee Cohen, MD
2.5 Hours
Identification and Management of Cardiometabolic Risk With Antipsychotic Medications
  • Recognize the Risk of Premature Mortality Associated with Major Mental Illness, And The Major Contribution Of Cardiovascular Disease And "Risk Equivalent" Conditions Like Diabetes
  • Identify The Increased Prevalence Of Specific Medical Conditions Among The Mentally Ill Population
  • Describe Commonly Occurring Cardiometabolic Risk Factors
  • Identify The Risk Of Cardiometabolic Side Effects Of Commonly Used Psychotropic Medications
  • Recognize Pharmacological And Behavioral Strategies To Modify Treatment Risk
  • Understand Methods To Detect Cardiometabolic Risk, As Well As Barriers To Screening, Monitoring And Management
John Newcomer, MD
1.75 Hours
Understanding Drug-Drug Interactions And Avoiding Untoward Outcomes
  • A Primer On Kinetic And Pharmacodynamic Interactions
  • Review Of The Big 4 Pharmacokinetic Mechanisms
  • A Primer On Pharmacogenomics
  • Review Of Drug-Drug Interactions
  • Everything You Wanted To Know About PGP But Were Afraid To Ask
Jack Krasuski, MD
2 Hours
Modern Management Of Cognition And Mood In Older Adults
  • Know How To Perform An Efficient Assessment To Diagnosis A Range Of Cognitive And Mood Disorders In Older Adults
  • Become Knowledgeable Of Pharmacological Treatments For These Conditions
  • Develop An Awareness Of The Importance Of Non-Pharmacological Strategies For Augmenting Pharmacotherapy
Gary Small, MD
1.5 Hours
Psychopharmacology Of Obsessive Compulsive Spectrum Disorders
  • Practical Review Of Neurobiology And Neurocircuitry Of OCD
  • Review Of Obsessive Compulsive Spectrum Disorders
    • First Line Treatments Of OCD
    • Treatment Of Resistant OCD
    • Novel Treatment Strategies
Eric Hollander, MD
1.25 Hours
Managing The Adult Patient With An Autism Spectrum Disorder
  • Overview Of Target Symptom Domains In ASD And Impact On Functioning Practical Review Of Neurobiology And Neurocircuitry
  • Psychopharmacology Of Social Cognition
  • Psychopharmacology Of Repetitive Behaviors
  • Psychopharmacology Of Disruptive Behaviors
  • Psychopharmacology Of Attention, Mood Instability And Epilepsy
  • Novel Treatment Strategies
Eric Hollander, MD
1.5 Hours
Managing The Dually Diagnosed Patient
  • Clinical Approaches To The “Dual Diagnosis” Patient
  • Solving Diagnostic Difficulties: Substance-Induced Psychiatric Symptoms Vs. A Separate Psychiatric Disorder?
  • Pharmacotherapy Of Psychiatric Disorders In Patients With Co-Occurring Substance Use Disorders
  • Is It Safe And Effective To Use Anti-Craving Agents In Patients With Co-Occurring Psychiatric Illness?
  • Integrated Treatment Of Substance Dependent Individuals With Coexisting Conditions
Richard Rosenthal, MD
1.25 Hours
Treatment Of Alcohol And Drug Abuse
  • When To Use Pharmacotherapy
  • How To Use Acamprosate, Naltrexone, And Disulfiram For Patients With Alcohol Dependence
  • Opioid Dependence Pharmacotherapy: Buprenorphine, Methadone, And Oral And Injectable Naltrexone
  • Integrating Pharmacotherapy With Psychosocial Treatments And Self-Help Groups Such As AA
  • Increasing Medication Adherence In Substance Dependent Patients
Richard Rosenthal, MD
Top

Faculty


Lee Cohen, MD

Lee Cohen, MD

Titles/Affiliations/Positions:

  • Associate Professor, Harvard Medical School, Boston, MA
  • Associate Psychiatrist, Massachusetts General Hospital, Boston, MA
  • Director, Perinatal Psychiatry Clinical Research Program, Massachusetts General Hospital, Boston, MA

Education:

  • MD, Albany Medical College, Albany, NY
  • Residency in Psychiatry, Massachusetts General Hospital, Boston, MA
  • Clinical Fellow in Psychiatry, Harvard Medical School, Boston, MA

Board Certifications:

  • Psychiatry, American Board of Psychiatry and Neurology

For more than 20 years, Dr. Cohen has been actively engaged in research, teaching, and clinical care related to psychiatric disorders throughout the female reproductive lifecycle.
After completing a chief residency in psychiatry, he founded the Perinatal and Reproductive Psychiatry Clinical Research Program, where he serves as Director. Along with colleagues in the Perinatal Program, Dr. Cohen helped to create and maintain the Perinatal Information Resource Center at www.womensmentalhealth.org.

Dr. Cohen has given more than 200 lectures nationally and internationally on issues in women’s mental health, as well as chairing numerous symposia. He also has experience in directing continuing medical education courses in the area of reproductive psychiatry.

Dr. Cohen has also shared his expertise through the authorship of more than 100 peer-reviewed articles and 30 book chapters. He is an ad hoc reviewer for more than 20 scholarly medical journals, an editorial board member for Archives of Women’s Mental Health, and co-editor of the text Mood and Anxiety Disorders During Pregnancy and Postpartum.

Eric Hollander, MD, DFAPA, FACNP

Eric Hollander, MD, DFAPA, FACNP

Titles/Affiliations/Positions:

  • Clinical Professor, Psychiatry and Behavioral Science, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY
  • Director, Autism and Obsessive-Compulsive Spectrum Program, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY

Education:

  • MD, State University of New York, Downstate Medical College, Brooklyn, NY
  • Resident and Chief Resident, Psychiatry, Mt. Sinai School of Medicine, New York, NY
  • NIMH Research Fellowship, Columbia University College of Physicians and Surgeons, Manhattan, NY

Board Certifications:

  • Psychiatry

Dr. Hollander has been listed under NY Magazine’s “Best Doctors” and “Best Doctors in America” numerous times. He has also received national research awards from the American Psychiatric Association and a Distinguished Investigator Award from the National Alliance for Research in Schizophrenia and Depression. Dr. Hollander has served as the Esther and Joseph Klingenstein Professor and Chair of Psychiatry and Director of the Seaver and Greater NY Autism Center for Excellence at Mount Sinai School of Medicine.

Dr. Hollander has published more than 450 scientific reports and edited nearly 20 books in the psychiatry field including The Clinical Manual of Impulse Control Disorders(2006). Dr. Hollander has also made frequent television appearances on Dateline NBC and the Today Show, as well as having interviews in the New York Times and People Magazine.

Jack Krasuski, MD

Jack Krasuski, MD

Titles/Affiliations/Positions:

  • Executive Director, American Physician Institute for Advanced Professional Studies, Oak Brook, IL

Education:

  • MD, University of Illinois Abraham Lincoln School of Medicine, Chicago, IL
  • Residency, Dept. of Psychiatry, University of Illinois Medical Center and Clinics at Chicago, Chicago, IL
  • Fellowship, Senior Staff Fellow at the National Institute on Aging, National Institutes of Health, Bethesda, MD

Board Certifications:

  • Psychiatry, American Board of Psychiatry and Neurology

Dr. Krasuski spent three years as a Senior Staff Fellow at the National Institute on Aging, NIH, where he did research in the neuroimaging of dementing disorders. Currently, he spends most of his time lecturing to thousands of physicians, annually, on psychiatric

John W. Newcomer, MD

John W. Newcomer, MD

Titles/Affiliations/Positions:

  • Leonard M. Miller Professor of Psychiatry and Behavioral Sciences, Leonard M. Miller School of Medicine, University of Miami, Miami, FL

Education:

  • MD, Wayne State University School of Medicine, Detroit, MI
  • Residency and Research Fellowship, Stanford University School of Medicine

Board Certifications:

  • Psychiatry

Dr. Newcomer has been lecturing in the field of psychiatry for over 20 years, and has been a NIH-funded principal investigator over that entire period. He has served in a number of research leadership positions, including Medical Director of the Center for Clinical Studies at Washington University in St. Louis and Senior Associate Dean for Clinical Research at the University of Miami in Florida. He has received numerous honors and awards including Distinguished Fellow of the American Psychiatric Association and Chairman of the Medicaid Drug Use Review Board for the state of Missouri from 1997-2011. Dr. Newcomer has over 140 papers and chapters, and serves on several editorial boards including the Journal of Clinical Psychiatry, Schizophrenia Bulletin, Neuropsychopharmacology, and the Journal of Obesity.

Richard N. Rosenthal, MD

Richard N. Rosenthal, MD

Titles/Affiliations/Positions:

  • Professor of Clinical Psychiatry, Columbia University College of Physicians and Surgeons, New York, NY
  • Chairman, Department of Psychiatry, St. Luke’s-Roosevelt Hospital Center, New York, NY
  • Senior Associate Dean, St. Luke’s Roosevelt Affiliation with Columbia University, New York, NY

Education:

  • MD, State University of New York, Downstate Medical Center, Brooklyn,  NY
  • Internship and Resident, Psychiatry, Mount Sinai Hospital, New York, NY

Board Certifications:

  • Psychiatry
  • Addiction Psychiatry

Dr. Rosenthal is a past president of both the American Academy of Addiction Psychiatry and the American Association for Technology in Psychiatry, a Distinguished Fellow of the American Psychiatric Association and a Fellow of the New York Academy of Medicine. Dr. Rosenthal has been appointed to the NY State Mental Health Services Council as well as receiving numerous awards and honors including the Founders Award of the American Academy of Addiction Psychiatry, more than ten years in New York Magazine's Best Doctors in New York and several years in The Best Doctors in America.

Dr. Rosenthal’s main research and clinical focus for more than 25 years has been on the evaluation and treatment of co-occurring substance use and other mental disorders. He was a Senior Fellow, SAMHSA Co-Occurring Disorders Center for Excellence and Co-Chairman of its National Steering Council, and is currently Senior Advisor to the Center for Excellence in Integrated Care. He has authored more than 80 peer-reviewed journal articles, invited reviews, book chapters, and books and serves on the editorial board of American Journal on Addictions. Dr. Rosenthal also maintains a private practice of psychotherapy and psychopharmacology for mood and addictive disorders.

Gary W. Small, MD

Gary W. Small, MD

Titles/Affiliations/Positions:

  • Professor, Department of Psychiatry and Behavioral Sciences, UCLA, Los Angeles, CA
  • Founding Director, UCLA Memory Clinic, UCLA, Los Angeles, CA>
  • Founding Director, Memory and Aging Research Center, Semel Institute for Neuroscience & Human Behavior, Los Angeles, CA
  • Director, UCLA Center on Aging, Los Angeles, CA

Education:

  • MD, University of Southern California School of Medicine, Los Angeles, CA
  • Chief Resident, Psychiatric Consultation-Liason, Massachusetts General Hospital, Boston, MA
  • Fellow in Geriatric Psychiatry, UCLA School of Medicine, Los Angeles, CA

Board Certifications:

  • Psychiatry
  • Geriatric Psychiatry

Dr. Small is a nationally recognized leader in the field of Geriatric Psychiatry with over 25 years of experience educating and researching. He has received numerous awards in recognition of his work, including the Jack Weinberg Award from the American Psychiatric Association, as well as the Senior Investigator Award from the American Association for Geriatric Psychiatry. Dr. Small is the Director of the UCLA Center on Aging as well as Imaging Core at UCLA Alzheimer’s Disease Research Center. He is also the Founding Director of the UCLA Memory Clinic and the Memory and Aging Research Center, Semel Institute for Neuroscience & Human Behavior.

Dr. Small has authored more than 400 publications as well serving on the review board numerous medical journals such as Journal of Geriatric Psychiatry and Neurology. Dr. Small has also made regular national television appearances on shows such as ABC World News.

-
Top

CME Accreditation

Accreditation Statement:

This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of PeerPoint Medical Education Institute and The American Physician Institute for Advanced Professional Studies, LLC. PeerPoint Medical Education Institute is accredited by the ACCME to sponsor continuing medical education for physicians.

Credit Designation:

PeerPoint Medical Education Institute designates this educational activity for a maximum of 25 AMA PRA Category 1 Credits™(with 8 of these credits designated as Self-Assessment). Physicians should only claim credit commensurate with the extent of their participation in the activity. This CME activity was planned and produced in accordance with the ACCME Essentials.

The American Board of Psychiatry and Neurology has reviewed the 2012 Master Psychopharmacology Course and has approved this program as a part of a comprehensive Self-Assessment Program, which is mandated by the ABMS as a necessary component of Maintenance of Certification.

-
Top